Clinical Trials in Michigan

Showing 641-660 of 16,154 trials

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

NCT07259317

This is a Phase 2, single-arm study to evaluate the safety and efficacy of relacorilant in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic adenocarcinoma (PDAC).

AdenocarcinomaCarcinoma, Pancreatic Ductal

Corcept Therapeutics60 participantsStarted Jan 2026

Scottsdale, Arizona, United States • Los Angeles, California, United States • Atlanta, Georgia, United States +7 more locations

RECRUITINGPhase 2/362 miles

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

NCT07440225

Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD). Available standard (usual) treatments for NVAMD, such as aflibercept, may not work for every person. Researchers want to learn if a trial medicine called tiespectus (also called MK-8748 or EYE201) can treat NVAMD. The goal of this trial is to learn if tiespectus works as well as aflibercept to treat NVAMD.

Macular DegenerationAge-Related Macular DegenerationChoroidal Neovascularization+1 more

EyeBiotech Ltd.960 participantsStarted Mar 2026

Modesto, California, United States • Redlands, California, United States • Sacramento, California, United States +17 more locations

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Find Trials by Condition in Michigan

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis

A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

A Study of BMS-986504 in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)

A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia

Pyruvate Kinase Deficiency Global Longitudinal Registry

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury

Evaluation of the Efficacy and Safety of LevoCept

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP

Electrical Stimulation for the Treatment of Glaucoma

A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies

Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System